COVID-19

Patients with COVID-19 faced a significant emotional and financial burden after discharge from treatment.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

In the midst of the COVID-19 pandemic, it is important that individuals who are at higher risk for poor outcomes from infection with vaccine-preventable diseases remain up-to-date with their immunizations.

Most web searches for insomnia were done between midnight and 5 am, when people are typically asleep.

The study showed that 95% of women who tested positive for COVID-19 during pregnancy had no adverse outcomes, with the virus being transmitted to the fetus in just 3% of the cases.

Here are 4 ways to continue protecting partners, children, parents, and grandparents during the COVID-19 pandemic.

A recent poll showed that more than 1 in 8 Americans engaged in a video consult with a health care professional in recent months.

As the COVID-19 pandemic continues, pharmacists and other health care professionals have had to contend simultaneously with the continuing substance use epidemic.

The authors noted that if regulatory agencies maintain the well-documented safety testing protocols that have been developed over the years, COVID-19 vaccines will be safe and trustworthy.

By volunteering with the American Red Cross, pharmacists can continue to help support communities who are struggling during the coronavirus disease 2019 (COVID-19) pandemic.

In the midst of a pandemic, visibility and interoperability have never been more critical when it comes to medication inventory.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Webinar participants discuss best practices for pharmacists with patients contending with both issues.

Cultural norms are some of the most powerful forces in nature, and I did not think we had it in us as Americans to wear masks.

The companies expect to product up to 50 million doses globally before the end of 2020, and up to 1.3 billion doses by the end of 2021.

Health care professionals can continue to educate their communities about the importance of correct and consistent mask wearing, frequent handwashing, and social distancing.

The NCPA and NACDS both applauded the HHS announcement regarding the partnerships with national and regional chain pharmacies and independent pharmacies to maximize access to COVID-19 vaccines.

Pharmacy Times® interviewed Maryland Secretary of Commerce Kelly M. Schulz on the economic impact of the COVID-19 pandemic on small businesses, such as community pharmacies.

The findings show that vaping changes the expression of genes and production of proteins in respiratory cells, as well as altering virus-specific antibody production, according to the study.

Those wearing a facemask while exercising may feel an increased sensation of dyspnea, however, there is little evidence that this medical condition is occurring.

The study was done in an effort to help quickly develop pharmaceutical treatments for COVID-19 by repurposing existing drugs known to effectively treat other viral diseases, according to the study authors.

Results of a recent study confirmed that patients already taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) should not discontinue taking them due to COVID-19 infection.

Pharmacy Times spoke with Michael Haydock, senior director of content for cardiovascular, metabolic, and infectious diseases at Informa Pharma Intelligence, about investigational therapeutics for COVID-19 and what’s in the pipeline.

Patients may develop a vitamin C deficiency over the course of their COVID-19 illness, since vitamin C is consumed at a more rapid rate if an infection is active.

Moderna’s novel coronavirus disease 2019 vaccine candidate, mRNA-1273, showed 94.5% efficacy in preventing the virus, according to preliminary results from the ongoing phase 3 COVE trial.